Jülich Development Receives US Approval
A substance developed at Forschungszentrum Jülich, which is used to detect brain tumours has overcome an important regulatory hurdle in the US: the US Food and Drug Administration has approved the drug 18F-fluoroethyl-L-tyrosine – FET, for short – for certain diagnostic applications for glioma.























